IMTX compared with NRIX: revenue, margins and what each company keeps, and the suppliers and customers both name

IMTXImmatics N.V.

Mkt capRevenueRevenue

NRIXNurix Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IMTXImmatics N.V.

NRIXNurix Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IMTXImmatics N.V.

7.05▼−0.09%· post 7.07

Mkt cap$946.5MRevenue—Revenue—

NRIXNurix Therapeutics, Inc.

25.82▲+0.46%· post 17.50

ClosedNov 3 '26

Mkt cap$2.8BRevenue$673MQ3 FY26Revenue$84MFY25

Compare

ClosedNov 3 '26

IMTXImmatics N.V.

NRIXNurix Therapeutics, Inc.

7.05▼−0.09%post 7.07

Price

25.82▲+0.46%post 17.50

$946.5M

Mkt cap

$2.8B

—

Revenue

$673MQ3 FY26

—

Revenue

$84MFY25

IMTX7.05▼−0.09%vsNRIX25.82▲+0.46%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMTX 2

BMYBristol-Myers Squibbcustomer

MRNAModernaTXcustomer

Shared 0

No shared counterparties.

Only NRIX 7

GILDGilead Sciences, Inc. (Gilead)customer

PFEPfizer Inc. (Pfizer)customer

SNYSanofi S.A. (Sanofi)customer

SNYNFSanoficustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

3 more · NRIX chain ›

Price

rebased to 0%

IMTX, solidNRIX, dashed